MicroRNA machinery genes as novel biomarkers for cancer

Frontiers in Oncology

Volumn 4 MAY, Issue , 2014, Pages

  Huang, Jing Tao ^a   Wang, Jin ^b   Srivastava, Vibhuti ^b   Sen, Subrata ^b   Liu, Song Mei ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Alterations; Biomarker; Cancer; Machinery genes; MiRNA

Indexed keywords

ARGONAUTE 2 PROTEIN; DICER; DIGEORGE CRITICAL REGION 8; DROSHA PROTEIN; EXPORTIN 5; MICRORNA; PEPTIDES AND PROTEINS; RNA BINDING PROTEIN; RNA INDUCED SILENCING COMPLEX; TAR RNA BINDING PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

CARCINOGENESIS; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE STRUCTURE; HUMAN; NEOPLASM; NONHUMAN; REVIEW;

EID: 84904701315     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00113     Document Type: Review

References (122)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell (2009) 136:215-33. doi: 10.1016/j.cell.2009.01.002
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 116:281-97. doi:10.1016/S0092-8674(04)00045-5
3. Sand M, Skrygan M, Georgas D, Sand D, Gambichler T, Altmeyer P, et al. The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi. Cell Tissue Res (2012) 350:119-26. doi:10.1007/s00441-012-1446-0
4. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2009) 19:92-105. doi:10.1101/gr.082701.108
5. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human microRNA targets. PLoS Biol (2004) 2:e363. doi:10.1371/journal.pbio.0020363
6. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature (2000) 408:86-9. doi:10.1038/35040556
7. Shin C, Nam JW, Farh KK, Chiang HR, Shkumatava A, Bartel DP. Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell (2010) 38:789-802. doi:10.1016/j.molcel.2010.06.005
8. Lal A, Navarro F, Maher CA, Maliszewski LE, Yan N, O'Day E, et al. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol Cell (2009) 35:610-25. doi:10.1016/j.molcel.2009.08.020
9. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the microprocessor complex. Nature (2004) 432:231-5. doi:10.1038/nature03049
10. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, et al. The microprocessor complex mediates the genesis of microRNAs. Nature (2004) 432:235-40. doi:10.1038/nature03120
11. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature (2003) 425:415-9. doi:10.1038/nature01957
12. Han J, Pedersen JS, Kwon SC, Belair CD, Kim YK, Yeom KH, et al. Posttranscriptional crossregulation between Drosha and DGCR8. Cell (2009) 136:75-84. doi:10.1016/j.cell.2008.10.053
13. Triboulet R, Chang HM, Lapierre RJ, Gregory RI. Post-transcriptional control of DGCR8 expression by the microprocessor. RNA (2009) 15:1005-11. doi:10.1261/rna.1591709
14. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science (2004) 303:95-8. doi:10.1126/science.1090599
15. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev (2003) 17:3011-6. doi:10.1101/gad.1158803
16. Bohnsack MT, Czaplinski K, Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA (2004) 10:185-91. doi:10.1261/rna.5167604
17. Lee HY, Doudna JA. TRBP alters human precursor microRNA processing in vitro. RNA (2012) 18:2012-9. doi:10.1261/rna.035501.112
18. Haase AD, Jaskiewicz L, Zhang H, Laine S, Sack R, Gatignol A, et al. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep (2005) 6:961-7. doi:10.1038/sj.embor.7400509
19. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature (2005) 436:740-4. doi:10.1038/nature03868
20. Lamontagne B, Larose S, Boulanger J, Elela SA. The RNase III family: a conserved structure and expanding functions in eukaryotic dsRNA metabolism. Curr Issues Mol Biol (2001) 3:71-8.
21. Senturia R, Laganowsky A, Barr I, Scheidemantle BD, Guo F. Dimerization and heme binding are conserved in amphibian and starfish homologues of the microRNA processing protein DGCR8. PLoS One (2012) 7:e39688. doi:10.1371/journal.pone.0039688
22. Sohn SY, Bae WJ, Kim JJ, Yeom KH, Kim VN, Cho Y. Crystal structure of human DGCR8 core. Nat Struct Mol Biol (2007) 14:847-53. doi:10.1038/nsmb1294
23. Tsunetsugu-Yokota Y, Yamamoto T. Mammalian microRNAs: post-transcriptional gene regulation in RNA virus infection and therapeutic applications. Front Microbiol (2010) 1:108. doi:10.3389/fmicb.2010.00108
24. Ding C, Li C, Wang H, Li B, Guo Z. A miR-SNP of the XPO5 gene is associated with advanced non-small-cell lung cancer. Onco Targets Ther (2013) 6:877-81. doi:10.2147/OTT.S48284
25. Grosshans H, Bussing I. MicroRNA biogenesis takes another single hit from microsatellite instability. Cancer Cell (2010) 18:295-7. doi:10.1016/j.ccr.2010.10.005
26. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature (2001) 409:363-6. doi:10.1038/35053110
27. Park JE, Heo I, Tian Y, Simanshu DK, Chang H, Jee D, et al. Dicer recognizes the 5' end of RNA for efficient and accurate processing. Nature (2011) 475:201-5. doi:10.1038/nature10198
28. Carmell MA, Hannon GJ. RNase III enzymes and the initiation of gene silencing. Nat Struct Mol Biol (2004) 11:214-8. doi:10.1038/nsmb729
29. Ohishi K, Nakano T. A forward genetic screen to study mammalian RNA interference: essential role of RNase IIIa domain of Dicer1 in 3' strand cleavage of dsRNA in vivo. FEBS J (2012) 279:832-43. doi:10.1111/j.1742-4658.2012.08474.x
30. Gurtan AM, Lu V, Bhutkar A, Sharp PA. In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs. RNA (2012) 18:1116-22. doi:10.1261/rna.032680.112
31. Hock J, Meister G. The argonaute protein family. Genome Biol (2008) 9:210. doi:10.1186/gb-2008-9-2-210
32. Elkayam E, Kuhn CD, Tocilj A, Haase AD, Greene EM, Hannon GJ, et al. The structure of human argonaute-2 in complex with miR-20a. Cell (2012) 150:100-10. doi:10.1016/j.cell.2012.05.017
33. Gaynor JW, Campbell BJ, Cosstick R. RNA interference: a chemist's perspective. Chem Soc Rev (2010) 39:4169-84. doi:10.1039/b920362c
34. Song JJ, Smith SK, Hannon GJ, Joshua-Tor L. Crystal structure of argonaute and its implications for RISC slicer activity. Science (2004) 305:1434-7. doi:10.1126/science.1102514
35. Wang Y, Sheng G, Juranek S, Tuschl T, Patel DJ. Structure of the guide-strand-containing argonaute silencing complex. Nature (2008) 456:209-13. doi:10.1038/nature07315
36. Boland A, Tritschler F, Heimstadt S, Izaurralde E, Weichenrieder O. Crystal structure and ligand binding of the MID domain of a eukaryotic argonaute protein. EMBO Rep (2010) 11:522-7. doi:10.1038/embor.2010.81
37. Daniels SM, Melendez-Pena CE, Scarborough RJ, Daher A, Christensen HS, El Far M, et al. Characterization of the TRBP domain required for dicer interaction and function in RNA interference. BMC Mol Biol (2009) 10:38. doi:10.1186/1471-2199-10-38
38. Yamashita S, Nagata T, Kawazoe M, Takemoto C, Kigawa T, Guntert P, et al. Structures of the first and second double-stranded RNA-binding domains of human TAR RNA-binding protein. Protein Sci (2011) 20:118-30. doi:10.1002/pro.543
39. Daniels SM, Gatignol A. The multiple functions of TRBP, at the hub of cell responses to viruses, stress, and cancer. Microbiol Mol Biol Rev (2012) 76:652-66. doi:10.1128/MMBR.00012-12
40. Laraki G, Clerzius G, Daher A, Melendez-Pena C, Daniels S, Gatignol A. Interactions between the double-stranded RNA-binding proteins TRBP and PACT define the Medipal domain that mediates protein-protein interactions. RNA Biol (2008) 5:92-103. doi:10.4161/rna.5.2.6069
41. Knuckles P, Vogt MA, Lugert S, Milo M, Chong MM, Hautbergue GM, et al. Drosha regulates neurogenesis by controlling neurogenin 2 expression independent of microRNAs. Nat Neurosci (2012) 15:962-9. doi:10.1038/nn.3139
42. Chong MM, Zhang G, Cheloufi S, Neubert TA, Hannon GJ, Littman DR. Canonical and alternate functions of the microRNA biogenesis machinery. Genes Dev (2010) 24:1951-60. doi:10.1101/gad.1953310
43. Karginov FV, Cheloufi S, Chong MM, Stark A, Smith AD, Hannon GJ. Diverse endonucleolytic cleavage sites in the mammalian transcriptome depend upon microRNAs, Drosha, and additional nucleases. Mol Cell (2010) 38:781-8. doi:10.1016/j.molcel.2010.06.001
44. Shenoy A, Blelloch R. Genomic analysis suggests that mRNA destabilization by the microprocessor is specialized for the auto-regulation of Dgcr8. PLoS One (2009) 4:e6971. doi:10.1371/journal.pone.0006971
45. Wu Q, Song R, Ortogero N, Zheng H, Evanoff R, Small CL, et al. The RNase III enzyme DROSHA is essential for microRNA production and spermatogenesis. J Biol Chem (2012) 287:25173-90. doi:10.1074/jbc.M112.362053
46. Oskowitz AZ, Penfornis P, Tucker A, Prockop DJ, Pochampally R. Drosha regulates hMSCs cell cycle progression through a miRNA independent mechanism. Int J Biochem Cell Biol (2011) 43:1563-72. doi:10.1016/j.biocel.2011.07.005
47. Wu H, Xu H, Miraglia LJ, Crooke ST. Human RNase III is a 160-kDa protein involved in preribosomal RNA processing. J Biol Chem (2000) 275:36957-65. doi:10.1074/jbc.M005494200
48. Fenelon K, Mukai J, Xu B, Hsu PK, Drew LJ, Karayiorgou M, et al. Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex. Proc Natl Acad Sci U S A (2011) 108:4447-52. doi:10.1073/pnas.1101219108
49. Stark KL, Xu B, Bagchi A, Lai WS, Liu H, Hsu R, et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet (2008) 40:751-60. doi:10.1038/ng.138
50. Chapnik E, Sasson V, Blelloch R, Hornstein E. Dgcr8 controls neural crest cells survival in cardiovascular development. Dev Biol (2012) 362:50-6. doi:10.1016/j.ydbio.2011.11.008
51. Chen Z, Wu J, Yang C, Fan P, Balazs L, Jiao Y, et al. DiGeorge syndrome critical region 8 (DGCR8) protein-mediated microRNA biogenesis is essential for vascular smooth muscle cell development in mice. J Biol Chem (2012) 287:19018-28. doi:10.1074/jbc.M112.351791
52. Li Z, He X, Feng J. Dicer is essential for neuronal polarity. Int J Dev Neurosci (2012) 30:607-11. doi:10.1016/j.ijdevneu.2012.08.002
53. Kanji MS, Martin MG, Bhushan A. Dicer1 is required to repress neuronal fate during endocrine cell maturation. Diabetes (2013) 62:1602-11. doi:10.2337/db12-0841
54. Davis TH, Cuellar TL, Koch SM, Barker AJ, Harfe BD, McManus MT, et al. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J Neurosci (2008) 28:4322-30. doi:10.1523/JNEUROSCI.4815-07.2008
55. Lynn FC, Skewes-Cox P, Kosaka Y, McManus MT, Harfe BD, German MS. MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes (2007) 56:2938-45. doi:10.2337/db07-0175
56. Morita S, Hara A, Kojima I, Horii T, Kimura M, Kitamura T, et al. Dicer is required for maintaining adult pancreas. PLoS One (2009) 4:e4212. doi:10.1371/journal.pone.0004212
57. Mandelbaum AD, Melkman-Zehavi T, Oren R, Kredo-Russo S, Nir T, Dor Y, et al. Dysregulation of Dicer1 in beta cells impairs islet architecture and glucose metabolism. Exp Diabetes Res (2012) 2012:470302. doi:10.1155/2012/470302
58. Kalis M, Bolmeson C, Esguerra JL, Gupta S, Edlund A, Tormo-Badia N, et al. Beta-cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus. PLoS One (2011) 6:e29166. doi:10.1371/journal.pone.0029166
59. Greenlee AR, Shiao MS, Snyder E, Buaas FW, Gu T, Stearns TM, et al. Deregulated sex chromosome gene expression with male germ cell-specific loss of Dicer1. PLoS One (2012) 7:e46359. doi:10.1371/journal.pone.0046359
60. Brady BL, Rupp LJ, Bassing CH. Requirement for dicer in survival of proliferating thymocytes experiencing DNA double-strand breaks. J Immunol (2013) 190:3256-66. doi:10.4049/jimmunol.1200957
61. Czech B, Hannon GJ. Small RNA sorting: matchmaking for argonautes. Nat Rev Genet (2011) 12:19-31. doi:10.1038/nrg2916
62. O'Carroll D, Mecklenbrauker I, Das PP, Santana A, Koenig U, Enright AJ, et al. A slicer-independent role for argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev (2007) 21:1999-2004. doi:10.1101/gad.1565607
63. Olejniczak SH, La Rocca G, Gruber JJ, Thompson CB. Long-lived microRNA-argonaute complexes in quiescent cells can be activated to regulate mitogenic responses. Proc Natl Acad Sci U S A (2013) 110:157-62. doi:10.1073/pnas.1219958110
64. Schaefer A, Im HI, Veno MT, Fowler CD, Min A, Intrator A, et al. Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction. J Exp Med (2010) 207:1843-51. doi:10.1084/jem.20100451
65. Kim BS, Im YB, Jung SJ, Park CH, Kang SK. Argonaute2 regulation for K+ channel-mediated human adipose tissue-derived stromal cells self-renewal and survival in nucleus. Stem Cells Dev (2012) 21:1736-48. doi:10.1089/scd.2011.0388
66. Shen J, Xia W, Khotskaya YB, Huo L, Nakanishi K, Lim SO, et al. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature (2013) 497:383-7. doi:10.1038/nature12080
67. Redfern AD, Colley SM, Beveridge DJ, Ikeda N, Epis MR, Li X, et al. RNA-induced silencing complex (RISC) proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulators. Proc Natl Acad Sci U S A (2013) 110:6536-41. doi:10.1073/pnas.1301620110
68. Sanghvi VR, Steel LF. The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR. J Virol (2011) 85:12614-21. doi:10.1128/JVI.05240-11
69. Zhang C, Huys A, Thibault PA, Wilson JA. Requirements for human Dicer and TRBP in microRNA-122 regulation of HCV translation and RNA abundance. Virology (2012) 433:479-88. doi:10.1016/j.virol.2012.08.039
70. Christensen HS, Daher A, Soye KJ, Frankel LB, Alexander MR, Laine S, et al. Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production. J Virol (2007) 81:5121-31. doi:10.1128/JVI.01511-06
71. Eekels JJ, Geerts D, Jeeninga RE, Berkhout B. Long-term inhibition of HIV-1 replication with RNA interference against cellular co-factors. Antiviral Res (2011) 89:43-53. doi:10.1016/j.antiviral.2010.11.005
72. Kok KH, Ng MH, Ching YP, Jin DY. Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA. J Biol Chem (2007) 282:17649-57. doi:10.1074/jbc.M611768200
73. Daher A, Laraki G, Singh M, Melendez-Pena CE, Bannwarth S, Peters AH, et al. TRBP control of PACT-induced phosphorylation of protein kinase R is reversed by stress. Mol Cell Biol (2009) 29:254-65. doi:10.1128/MCB.01030-08
74. Melo S, Villanueva A, Moutinho C, Davalos V, Spizzo R, Ivan C, et al. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A (2011) 108:4394-9. doi:10.1073/pnas.1014720108
75. Bohnsack MT, Regener K, Schwappach B, Saffrich R, Paraskeva E, Hartmann E, et al. Exp5 exports eEF1A via tRNA from nuclei and synergizes with other transport pathways to confine translation to the cytoplasm. EMBO J (2002) 21:6205-15. doi:10.1093/emboj/cdf613
76. Bennasser Y, Chable-Bessia C, Triboulet R, Gibbings D, Gwizdek C, Dargemont C, et al. Competition for XPO5 binding between Dicer mRNA, pre-miRNA and viral RNA regulates human Dicer levels. Nat Struct Mol Biol (2011) 18:323-7. doi:10.1038/nsmb.1987
77. Iwasaki YW, Kiga K, Kayo H, Fukuda-Yuzawa Y, Weise J, Inada T, et al. Global microRNA elevation by inducible Exportin 5 regulates cell cycle entry. RNA (2013) 19:490-7. doi:10.1261/rna.036608.112
78. Muqbil I, Bao B, Abou-Samra AB, Mohammad RM, Azmi AS. Nuclear export mediated regulation of microRNAs: potential target for drug intervention. Curr Drug Targets (2013) 14:1094-100. doi:10.2174/1389450111314100002
79. Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, et al. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res (2008) 14:7956-62. doi:10.1158/1078-0432.CCR-08-1199
80. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal (2013) 6:l1. doi:10.1126/scisignal.2004088
81. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov (2012) 2:401-4. doi:10.1158/2159-8290.CD-12-0095
82. Sand M, Gambichler T, Skrygan M, Sand D, Scola N, Altmeyer P, et al. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer. Cancer Invest (2010) 28:649-53. doi:10.3109/07357901003630918
83. Muralidhar B, Winder D, Murray M, Palmer R, Barbosa-Morais N, Saini H, et al. Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles. J Pathol (2011) 224:496-507. doi:10.1002/path.2898
84. Papachristou DJ, Rao UN, Korpetinou A, Giannopoulou E, Sklirou E, Kontogeorgakos V, et al. Prognostic significance of Dicer cellular levels in soft tissue sarcomas. Cancer Invest (2012) 30:172-9. doi:10.3109/07357907.2011.633293
85. Papachristou DJ, Sklirou E, Corradi D, Grassani C, Kontogeorgakos V, Rao UN. Immunohistochemical analysis of the endoribonucleases Drosha, Dicer and Ago2 in smooth muscle tumours of soft tissues. Histopathology (2012) 60:E28-36. doi:10.1111/j.1365-2559.2012.04192.x
86. Lin RJ, Lin YC, Chen J, Kuo HH, Chen YY, Diccianni MB, et al. microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res (2010) 70:7841-50. doi:10.1158/0008-5472.CAN-10-0970
87. Torres A, Torres K, Paszkowski T, Jodlowska-Jedrych B, Radomanski T, Ksiazek A, et al. Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer. Tumour Biol (2011) 32:769-76. doi:10.1007/s13277-011-0179-0
88. Guo X, Liao Q, Chen P, Li X, Xiong W, Ma J, et al. The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma. J Cancer Res Clin Oncol (2012) 138:49-56. doi:10.1007/s00432-011-1058-1
89. Dedes KJ, Natrajan R, Lambros MB, Geyer FC, Lopez-Garcia MA, Savage K, et al. Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. Eur J Cancer (2011) 47:138-50. doi:10.1016/j.ejca.2010.08.007
90. Shu GS, Yang ZL, Liu DC. Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances. Pathol Res Pract (2012) 208:392-7. doi:10.1016/j.prp.2012.05.001
91. Kim B, Lee JH, Park JW, Kwon TK, Baek SK, Hwang I, et al. An essential microRNA maturing microprocessor complex component DGCR8 is up-regulated in colorectal carcinomas. Clin Exp Med (2013). doi:10.1007/s10238-013-0243-8
92. Jafari N, Dogaheh HP, Bohlooli S, Oyong GG, Shirzad Z, Alibeiki F, et al. Expression levels of microRNA machinery components Drosha, Dicer and DGCR8 in human (AGS, HepG2, and KEYSE-30) cancer cell lines. Int J Clin Exp Med (2013) 6:269-74.
93. Guo Y, Tian P, Yang C, Liang Z, Li M, Sims M, et al. Silencing the double-stranded RNA binding protein DGCR8 inhibits ovarian cancer cell proliferation, migration, and invasion. Pharm Res (2013). doi:10.1007/s11095-013-1219-9
94. Wu D, Tao J, Xu B, Li P, Lu Q, Zhang W. Downregulation of Dicer, a component of the microRNA machinery, in bladder cancer. Mol Med Rep (2012) 5:695-9. doi:10.3892/mmr.2011.711
95. Han Y, Liu Y, Gui Y, Cai Z. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder. J Surg Oncol (2013) 107:201-5. doi:10.1002/jso.23214
96. Leaderer D, Hoffman AE, Zheng T, Fu A, Weidhaas J, Paranjape T, et al. Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis. Int J Mol Epidemiol Genet (2011) 2:9-18.
97. Kim MS, Oh JE, Kim YR, Park SW, Kang MR, Kim SS, et al. Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers. J Pathol (2010) 221:139-46. doi:10.1002/path.2683
98. Melo SA, Moutinho C, Ropero S, Calin GA, Rossi S, Spizzo R, et al. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell (2010) 18:303-15. doi:10.1016/j.ccr.2010.09.007
99. de Larrea CF, Navarro A, Tejero R, Tovar N, Diaz T, Cibeira MT, et al. Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation. Clin Cancer Res (2012) 18:3697-704. doi:10.1158/1078-0432.CCR-12-0191
100. Fu X, Xue C, Huang Y, Xie Y, Li Y. The activity and expression of microRNAs in prostate cancers. Mol Biosyst (2010) 6:2561-72. doi:10.1039/c0mb00100g
101. Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K, et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci (2005) 96:111-5. doi:10.1111/j.1349-7006.2005.00015.x
102. Khoshnaw SM, Rakha EA, Abdel-Fatah TM, Nolan CC, Hodi Z, Macmillan DR, et al. Loss of Dicer expression is associated with breast cancer progression and recurrence. Breast Cancer Res Treat (2012) 135:403-13. doi:10.1007/s10549-012-2169-3
103. Zhang J, Fan XS, Wang CX, Liu B, Li Q, Zhou XJ. Up-regulation of Ago2 expression in gastric carcinoma. Med Oncol (2013) 30:628. doi:10.1007/s12032-013-0628-2
104. Cheng N, Li Y, Han ZG. Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma. Hepatology (2013) 57:1906-18. doi:10.1002/hep.26202
105. Zhang X, Graves P, Zeng Y. Overexpression of human argonaute2 inhibits cell and tumor growth. Biochim Biophys Acta (2013) 1830:2553-61. doi:10.1016/j.bbagen.2012.11.013
106. Voller D, Reinders J, Meister G, Bosserhoff AK. Strong reduction of AGO2 expression in melanoma and cellular consequences. Br J Cancer (2013) 109:3116-24. doi:10.1038/bjc.2013.646
107. Sung H, Jeon S, Lee KM, Han S, Song M, Choi JY, et al. Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival. BMC Cancer (2012) 12:195. doi:10.1186/1471-2407-12-195
108. Caramuta S, Lee L, Ozata DM, Akcakaya P, Georgii-Hemming P, Xie H, et al. Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma. Blood Cancer J (2013) 3:e152. doi:10.1038/bcj.2013.49
109. Caramuta S, Lee L, Ozata DM, Akcakaya P, Xie H, Hoog A, et al. Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma. Endocr Relat Cancer (2013) 20:551-64. doi:10.1530/ERC-13-0098
110. Sand M, Skrygan M, Georgas D, Arenz C, Gambichler T, Sand D, et al. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog (2012) 51:916-22. doi:10.1002/mc.20861
111. Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, Sobol RW, et al. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res (2007) 67:2345-50. doi:10.1158/0008-5472.CAN-06-3533
112. Zheng ZH, Sun XJ, Fu WN, Guan Y, Gao F, Wang Y, et al. Decreased expression of DICER1 in gastric cancer. Chin Med J (Engl) (2007) 120:2099-104.
113. Pampalakis G, Diamandis EP, Katsaros D, Sotiropoulou G. Down-regulation of dicer expression in ovarian cancer tissues. Clin Biochem (2010) 43:324-7. doi:10.1016/j.clinbiochem.2009.09.014
114. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med (2008) 359:2641-50. doi:10.1056/NEJMoa0803785
115. Zhu DX, Fan L, Lu RN, Fang C, Shen WY, Zou ZJ, et al. Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia. Cancer Sci (2012) 103:875-81. doi:10.1111/j.1349-7006.2012.02234.x
116. Faggad A, Kasajima A, Weichert W, Stenzinger A, Elwali NE, Dietel M, et al. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer. Histopathology (2012) 61:552-61. doi:10.1111/j.1365-2559.2011.04110.x
117. Kuang Y, Cai J, Li D, Han Q, Cao J, Wang Z. Repression of Dicer is associated with invasive phenotype and chemoresistance in ovarian cancer. Oncol Lett (2013) 5:1149-54. doi:10.3892/ol.2013.1158
118. Zhang X, Cairns M, Rose B, O'Brien C, Shannon K, Clark J, et al. Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland. Int J Cancer (2009) 124:2855-63. doi:10.1002/ijc.24298
119. Martin MG, Payton JE, Link DC. Dicer and outcomes in patients with acute myeloid leukemia (AML). Leuk Res (2009) 33:e127. doi:10.1016/j.leukres.2009.02.003
120. Zhang B, Chen H, Zhang L, Dakhova O, Zhang Y, Lewis MT, et al. A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis. Oncogene (2013). doi:10.1038/onc.2013.281
121. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA, et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet (2009) 41:365-70. doi:10.1038/ng.317
122. Ota H, Sakurai M, Gupta R, Valente L, Wulff BE, Ariyoshi K, et al. ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing. Cell (2013) 153:575-89. doi:10.1016/j.cell.2013.03.024